GlaxoSmithKline Pharmaceuticals Limited announced that Mr. Sunder Ramachandran - Head of Commercial Excellence, has tendered his resignation effective from the close of business hours on 12th January 2024 to pursue other opportunities outside of the Company. As a result, he will also cease to be a Senior Management Personnel of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,699 INR | +2.72% | +9.13% | +42.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.25% | 5.33B | |
+48.79% | 781B | |
+41.74% | 639B | |
+19.43% | 330B | |
+7.18% | 293B | |
+17.23% | 248B | |
-0.16% | 221B | |
+11.66% | 217B | |
+4.53% | 162B | |
-3.92% | 157B |
- Stock Market
- Equities
- GLAXO Stock
- News GlaxoSmithKline Pharmaceuticals Limited
- GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Sunder Ramachandran as Head of Commercial Excellence, Effective 12 January 2024